O
53.31
2.88 (5.71%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Oruka Therapeutics, Inc. | Bearish | Bullish |
AIStockmoo Score
-0.3
| Analyst Consensus | -3.5 |
| Insider Activity | NA |
| Price Volatility | -4.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | -0.25 |
|
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 3.82% |
| % Held by Institutions | 86.62% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Fairmount Funds Management Llc | 31 Dec 2025 | 3,705,262 |
| Remedium Capital Partners, Llc | 31 Dec 2025 | 1,552,414 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 73.00 (BTIG, 36.94%) | Buy |
| Median | 50.00 (-6.21%) | |
| Low | 45.00 (Wedbush, -15.59%) | Buy |
| Average | 56.00 (5.05%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 29.95 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wedbush | 13 Jan 2026 | 45.00 (-15.59%) | Buy | 31.34 |
| BTIG | 12 Jan 2026 | 73.00 (36.93%) | Buy | 30.69 |
| UBS | 07 Jan 2026 | 50.00 (-6.21%) | Buy | 27.81 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Jan 2026 | Announcement | Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001 |
| 06 Jan 2026 | Announcement | Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 Aug 2024 | - | 28 Aug 2024 | 1.613 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 1.61 | 1 | 8.32 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |